Vova Ida LLC also dba Vova Ida Therapeutics (VIT) is organized around the development of drugs to treat age-related neurodegenerative diseases such as Alzheimers and Parkinsons diseases. Anchored in innovations made by the principal while at Scripps Research Institute, FL. VITs short-term objectives are preclinical development of existing therapeutic leads withthe longer-term goal being to turn neurodegenerative diseases into treatable disorders. Alzheimers and Parkinsons disease patients are typically offered drugs that address symptoms but nothing that will prevent further brain damage. With no disease-modifying treatment for any age-related neurodegenerative disease, Vova Ida is tackling development of drugs that will interfere directly with root cause of age-related neurodegenerative diseases: toxic protein aggregates damaging brain cells. V
